AWARD
R -- RECOVERY - ACTNOW Clinical Trial Support under Operation and Support of the Cancer Therapy Evaluation Program's Clinical Trials and Information Management Support
- Notice Date
- 9/1/2009
- Notice Type
- Award Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Archive Date
- 9/15/2009
- Point of Contact
- John R. Manouelian, Phone: (301) 435-3813, Richard L Hartmann, Phone: (301) 496-8620
- E-Mail Address
-
manouelj@mail.nih.gov, Richard.Hartmann@nih.gov
(manouelj@mail.nih.gov, Richard.Hartmann@nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSN261200422005C
- Award Date
- 8/31/2009
- Awardee
- The Emmes Corporation, 401 North Washington Street, Suite 700, Rockville, Maryland 20850, United States
- Award Amount
- $303,260
- Line Number
- Modification-10
- Description
- This action modifies an existing contract to provide funding for ACTNOW clinical trial support. This contract provides information support, database administration, data management, statistical support, and operation office requirements in support of clinical trials. Support includes compilation, collation, summarization, and analysis of data as well as literature and database searches and retrieval. In addition, contractor staff creates and/or maintains databases to track information concerning NCI-sponsored clinical trials. Rationale for using other than a fixed price: Uncertainties involved in contract performance do not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost reimbursement type action is appropriate. The primary purpose of the contract is to support the development of cancer clinical treatment trials sponsored by CTEP, NCI. The number of patients enrolled in each clinical trial is estimated at the start of the trial, but may fluctuate during the course of the study. In addition, the complexity of the protocols varies due to the phase of the study, disease to be studied, drug(s) to be used and the statistical design of the trial. The uncertainties involved with enrolling human participants and the complexities of protocol development make it difficult to predict the amount of services required to support the clinical trials.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/Awards/HHSN261200422005C.html)
- Record
- SN01936489-W 20090903/090902010626-57d7d7c62c8b33a8a261037d12d3e3d6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |